You searched for "drops"
Viral conjunctivitis and COVID-19
23 March 2020
|
COVID-19
A joint statement was released by the Royal College of Ophthalmologists and College of Optometrists on 19 March.
District hospitals key to unlocking Global South surgical conundrum
Patients attending first referral hospitals in low- and middle-income countries (LMICs) receive surgical care that is just as safe and effective as that provided by higher level referral centres, a new study reveals. Researchers found no significant difference in 30-day...Virtual COVID clinics
The clinics at Ystradgynlais Community Hospital are a little different of late. The nurses are still there, I still get tea with custard creams and the letters I dictate are still all written up by the next day. But there...Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of CMO after phacoemulsification
1 October 2015
| Jonathan Chan
|
Cataract and Refractive
This is a prospective randomised clinical trial study including patients older than 40 years with age related cataract and normal ophthalmic examination. The patients are randomised into three different groups and the objective of the study is to compare the...
Contemporary glaucoma therapy: spoilt for choice
1 April 2014
| Rod McNeil
|
Glaucoma
The goal of glaucoma management is to prevent visual loss and disease progression in the patient’s lifetime through effective lowering of intraocular pressure (IOP), the primary modifiable risk factor in glaucoma. Sustained and consistent IOP reduction is key to halting...
The inflammatory side-effect of Brimonidine
1 October 2016
| Saruban Pasu
|
Retina / Uvea / Vitreous
|
Brimonidine uveitis, drug induced uveitis
Brimonidine is a well established selective alpha-2 adreno-receptor agonist, used to lower intraocular pressure. This case series reports on 19 eyes affected by brimonidine induced uveitis. Mean age of the patients was 74 years and mean duration of brimonidine use...
An alternative to povidone-iodine for intravitreal injections?
1 February 2017
| Eulee Seow
|
Retina / Uvea / Vitreous
While povidone-iodine (5% aqueous) preparations have historically been considered the most effective antimicrobial prophylaxis for ophthalmic procedures and have been adopted as routine for intravitreal injections, post-procedure pain is a commonly recognized adverse event of IVI and has typically been...
Real-world experience and outcomes of SLT laser used as a first-line treatment in ocular hypertension patients in a United Kingdom National Health Service setting
3 October 2022
| Aiman Jamal, Shreya Haldar, Sarah Twallin, Asifa Shaikh
The management of raised intraocular pressure (IOP) in the context of ocular hypertension (OHT) and primary open angle glaucoma (POAG) remains a major contributor to the workload of ophthalmology units across the UK. Treatment of these conditions has historically centred...
Midland Eye performs its first Presserflo Microshunt to treat Glaucoma
Eye clinic, Midland Eye, announces the success of its first sight-saving Preserflo Microshunt glaucoma procedure.Presumed DALK stromal graft rejection following Covid-19 infection
Case report A 45-year-old healthy male patient with a past ocular history of keratoconus and right deep-anterior lamellar keratoplasty (DALK) graft performed 10 months prior, presented to our eye casualty clinic with a two-day history of right photophobia and epiphora....The Moorfields and UCL Laser course for ophthalmologists
6 November 2024
Moorfields Eye Hospital and UCL Institute of Ophthalmology are delighted to present this new laser course for ophthalmologists. This full day course will be delivered by Moorfields consultants and senior clinicians. It is designed to enhance both theoretical knowledge and...
Introduction of the Mydriasert insert at the Manchester Royal Eye Hospital
1 August 2018
| Rita McLauchlan, Julie Williams, Arun Brahma
|
Ophthalmology, Cornea / External Eye Disease
The authors report on a study to examine the effects of the Mydriasert insert on time, effects, patient comfort and tolerability at Manchester Royal Eye Hospital. Mydriasert is an insoluble ophthalmic insert indicated for mydriasis prior to ophthalmic surgery, which...